Andersson KE - Search Results

1

Bladder afferent signaling: recent findings.

Kanai A, Andersson KE. Kanai A, et al. Among authors: andersson ke. J Urol. 2010 Apr;183(4):1288-95. doi: 10.1016/j.juro.2009.12.060. Epub 2010 Feb 19. J Urol. 2010. PMID: 20171668 Free PMC article. Review.

2

Researching bladder afferents-determining the effects of β(3) -adrenergic receptor agonists and botulinum toxin type-A.

Kanai A, Wyndaele JJ, Andersson KE, Fry C, Ikeda Y, Zabbarova I, De Wachter S. Kanai A, et al. Among authors: andersson ke. Neurourol Urodyn. 2011 Jun;30(5):684-91. doi: 10.1002/nau.21102. Neurourol Urodyn. 2011. PMID: 21661014 Review.

3

Urothelial mucosal signaling and the overactive bladder-ICI-RS 2013.

Birder LA, Andersson KE, Kanai AJ, Hanna-Mitchell AT, Fry CH. Birder LA, et al. Among authors: andersson ke. Neurourol Urodyn. 2014 Jun;33(5):597-601. doi: 10.1002/nau.22604. Epub 2014 May 16. Neurourol Urodyn. 2014. PMID: 24838393 Free PMC article.

4

Mechanisms of action of botulinum neurotoxins, β3-adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI-RS 2011.

Kanai A, Zabbarova I, Oefelein M, Radziszewski P, Ikeda Y, Andersson KE. Kanai A, et al. Among authors: andersson ke. Neurourol Urodyn. 2012 Mar;31(3):300-8. doi: 10.1002/nau.21246. Epub 2012 Jan 24. Neurourol Urodyn. 2012. PMID: 22275187 Review.

5

Fibrosis and the bladder, implications for function ICI-RS 2017.

Fry CH, Kitney DG, Paniker J, Drake MJ, Kanai A, Andersson KE. Fry CH, et al. Among authors: andersson ke. Neurourol Urodyn. 2018 Jun;37(S4):S7-S12. doi: 10.1002/nau.23725. Neurourol Urodyn. 2018. PMID: 30133788 Review.

6

Bladder activation: afferent mechanisms.

Andersson KE. Andersson KE. Urology. 2002 May;59(5 Suppl 1):43-50. doi: 10.1016/s0090-4295(01)01637-5. Urology. 2002. PMID: 12007522 Review.

7

Bladder overactivity in mice after 1 week of outlet obstruction. Mainly afferent dysfunction?

Schröder A, Uvelius B, Newgreen D, Andersson KE. Schröder A, et al. Among authors: andersson ke. J Urol. 2003 Sep;170(3):1017-21. doi: 10.1097/01.ju.0000070926.39442.4c. J Urol. 2003. PMID: 12913762

8

Effects of tolterodine on afferent neurotransmission in normal and resiniferatoxin treated conscious rats.

Hedlund P, Streng T, Lee T, Andersson KE. Hedlund P, et al. Among authors: andersson ke. J Urol. 2007 Jul;178(1):326-31. doi: 10.1016/j.juro.2007.03.006. Epub 2007 May 15. J Urol. 2007. PMID: 17507042

9

Benign prostatic hyperplasia/obstruction ameliorated using a soluble guanylate cyclase activator.

Zabbarova IV, Ikeda Y, Kozlowski MG, Tyagi P, Birder LA, Chakrabarty B, Perera SK, Dhir R, Straub AC, Sandner P, Andersson KE, Drake MJ, Fry CH, Kanai AJ. Zabbarova IV, et al. Among authors: andersson ke. J Pathol. 2022 Apr;256(4):442-454. doi: 10.1002/path.5859. Epub 2022 Feb 15. J Pathol. 2022. PMID: 34936088 Free PMC article.

10

Effects of cannabinor, a novel selective cannabinoid 2 receptor agonist, on bladder function in normal rats.

Gratzke C, Streng T, Stief CG, Downs TR, Alroy I, Rosenbaum JS, Andersson KE, Hedlund P. Gratzke C, et al. Among authors: andersson ke. Eur Urol. 2010 Jun;57(6):1093-100. doi: 10.1016/j.eururo.2010.02.027. Epub 2010 Mar 1. Eur Urol. 2010. PMID: 20207474

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

978 results

Search Page